These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 13818502)

  • 21. [Anesthetic infiltration and resection of the internal saphenous nerve in the therapy of dystrophic ulcers of the lower extremity].
    SALVATI C
    Riforma Med; 1961 Nov; 75():1336-42. PubMed ID: 14496487
    [No Abstract]   [Full Text] [Related]  

  • 22. Vasodilators and the use of cyclospasmol in peripheral vascular disease.
    MAHL MM
    Angiology; 1961 Sep; 12():432-4. PubMed ID: 13765381
    [No Abstract]   [Full Text] [Related]  

  • 23. Speripheral vascular disease in general practice. Some experiences with meso-inositol-hexanicotinate.
    HAMILTON RR
    Practitioner; 1960 Mar; 184():367-9. PubMed ID: 14399278
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripheral vasodilation: methods of evaluation and the correlation with clinical practice.
    KAINDI F
    Angiology; 1960 Feb; 11():15-20. PubMed ID: 14404025
    [No Abstract]   [Full Text] [Related]  

  • 25. A quantitative appraisal of the value of vasodilators in occlusive peripheral arterial disease.
    GILLESPIE JA
    Bull Soc Int Chir; 1962; 21():69-72. PubMed ID: 13898634
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of cyclandelate (cyclospasmol) in treatment of circulatory disturbances.
    LESLIE RE
    Tex State J Med; 1960 May; 56():352-6. PubMed ID: 14415999
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic results of a new vasodilator in severe circulatory disorders of the lower extremities].
    WEGHAUPT K
    Wien Klin Wochenschr; 1957 Jan; 69(2):31-2. PubMed ID: 13409874
    [No Abstract]   [Full Text] [Related]  

  • 28. [On a new method of therapy of peripheral and cerebral circulatory disorders with 3-(methyioxyethylamino)-2-hydroxypropyltheophylline-beta-pyridinecarboxylic acid (complamin)].
    THIESEN J; FISCHER T
    Medizinische; 1959 Aug; 31-32():1427-32. PubMed ID: 13837851
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of a product of esterification of mandelic acid with 3,5,5-triethylcyclohexanol (cyclospasmol) in the treatment of peripheral arteriopathy].
    STARACE G; NOFERI A; PADULA R
    Gazz Med Ital; 1960 Apr; 119():133-6. PubMed ID: 13833815
    [No Abstract]   [Full Text] [Related]  

  • 30. [Actein, a fluid extract from Actaea racemosa, in the medical therapy of peripheral arteriopathies].
    STARACE G; NOFERI A; SALDAMARCO G
    Clin Ter; 1962 May; 22():823-9. PubMed ID: 13916295
    [No Abstract]   [Full Text] [Related]  

  • 31. [Demonstration on a trial treatment with Euclidan injected by the intra-arterial route of severe ischemic conditions of the lower limbs].
    BRUN F; PLAUCHU G; PERRIN A
    Lyon Med; 1962 Jun; 94():1413-25. PubMed ID: 13873962
    [No Abstract]   [Full Text] [Related]  

  • 32. [Contribution to the study of a pyrimido-pyrimidine derivative].
    LOPEZ MERINO V; ALGARRA GONZALEZ F; PONS ESPANA E
    Med Esp; 1961 Sep; 46():204-13. PubMed ID: 14466606
    [No Abstract]   [Full Text] [Related]  

  • 33. A new vasodilating and antispasmodic agent: isoxsuprine hydrochloride.
    KAINDL F; SAMUELS SS; SELMAN D; SHAFTEL H
    Angiology; 1959 Aug; 10():185-92. PubMed ID: 14404026
    [No Abstract]   [Full Text] [Related]  

  • 34. A clinical study of a musculotropic vasodilating compound.
    SHAFTEL HE; SAMUELS S; PADERNACHT E
    Angiology; 1961 Sep; 12():423-6. PubMed ID: 13750570
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of nylidrin hydrochloride on the skin and muscle temperature of patients with occlusive arterial disease of the lower extremities.
    ROEDLING HA; ROTH GM; SCHIRGER A; GIFFORD RW
    Angiology; 1960 Apr; 11():130-2. PubMed ID: 14438272
    [No Abstract]   [Full Text] [Related]  

  • 36. The case against vasodilator drugs in occlusive vascular disease of the legs.
    GILLESPIE JA
    Lancet; 1959 Dec; 2(7110):995-7. PubMed ID: 13850087
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic use of curare in peripheral vascular diseases and ulcers of the lower leg].
    ZRUBECKY G; WRUHS O
    Med Klin; 1952 Apr; 47(15):485-6. PubMed ID: 14956569
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience in the use of Duvadilan in peripheral vascular disorders].
    UJIIE K; SHA S; SHIBUI M; KAKIZAKI G
    Chiryo; 1961 Dec; 43():2262-4. PubMed ID: 13923625
    [No Abstract]   [Full Text] [Related]  

  • 39. [Leg ulcers of vascular origin].
    HOLAN V; KRCILEK A
    Cesk Dermatol; 1956 Aug; 31(4):201-4. PubMed ID: 13364959
    [No Abstract]   [Full Text] [Related]  

  • 40. Significance of a synthetic new vaso-dilator Caa-40 in the treatment of chronic leg ulcers.
    THIERS H; COLOMB D; FAYOLLE J; ARCADIO F; NOVE-JOSSERAND G
    J Med Lyon; 1959 Jun; 40(947):549-56. PubMed ID: 13673256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.